Scholarlink

Background <p>Metformin is the first-line treatment for type 2 diabetes mellitus in pediatric patients&#xa0;and it's&#xa0;prescriptions in children have increased for off-label indications. However, interindividual variability of metformin pharmacokinetics in children is not well studied. Metformin is a cation that&#xa0;requires multiple transporters&#xa0;for its absorption, distribution and elimination, including organic cation transporters (OCTs) and multidrug and toxin extrusion (MATE) transporters.</p> Methods <p>We conducted a 12 h clinical pharmacokinetic study in 36 pediatric patients&#xa0;(age, 7-21 years) treated with metformin and analyzed the data using non-compartmental and population pharmacokinetic models to describe metformin pharmacokinetics and associated covariates. The association of <i>OCT</i> and <i>MATE</i> genetic variants on metformin absorption and elimination&#xa0;was investigated.</p> Results <p>The dose-normalized plasma exposure of metformin varied by 3.3-fold among children. Renal clearance was higher in children compared to the reported data in healthy adults or adults with diabetes. Total body weight (TBW) and estimated glomerular filtration rate (eGFR) significantly affected metformin oral clearance. <i>OCT2</i> c.390 G &gt; T (p.Thr130 = , rs624249) was associated with metformin oral clearance and secretary clearance, whereas <i>OCT3</i> c.-29G &gt; A (rs555754) and c.360 C &gt; T (p.Arg120 = , rs668871) were significantly associated with the absorption rate constant and oral clearance.</p> Conclusion <p>Metformin dosing in children can be optimized based on TBW, eGFR, and <i>OCT2/3</i> genetic variants to improve its safety and efficacy.</p> Impact <p><UnorderedList Mark="Bullet"> <ItemContent> <p>Metformin pharmacokinetics is highly variable, and limited data are available on the pediatric population.</p> </ItemContent> <ItemContent> <p>Total body weight and estimated glomerular filtration rate are associated with metformin oral clearance.</p> </ItemContent> <ItemContent> <p><i>OCT2/3</i> genetic variants can influence the elimination and absorption of metformin.</p> </ItemContent> <ItemContent> <p>Consideration of population factors associated with metformin pharmacokinetics in dose selection can improve its safety and efficacy.</p> </ItemContent> </UnorderedList></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Interindividual variability in metformin pharmacokinetics in pediatric patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月3日

查看全文
  • Anoud Sameer Ailabouni,
  • Kelsee Halpin,
  • Erin C. Boone,
  • Andrea Gaedigk,
  • Takanobu Nadai,
  • Kei Irie,
  • Tomoyuki Mizuno,
  • J. Steven Leeder,
  • Bhagwat Prasad

摘要

Background

Metformin is the first-line treatment for type 2 diabetes mellitus in pediatric patients and it's prescriptions in children have increased for off-label indications. However, interindividual variability of metformin pharmacokinetics in children is not well studied. Metformin is a cation that requires multiple transporters for its absorption, distribution and elimination, including organic cation transporters (OCTs) and multidrug and toxin extrusion (MATE) transporters.

Methods

We conducted a 12 h clinical pharmacokinetic study in 36 pediatric patients (age, 7-21 years) treated with metformin and analyzed the data using non-compartmental and population pharmacokinetic models to describe metformin pharmacokinetics and associated covariates. The association of OCT and MATE genetic variants on metformin absorption and elimination was investigated.

Results

The dose-normalized plasma exposure of metformin varied by 3.3-fold among children. Renal clearance was higher in children compared to the reported data in healthy adults or adults with diabetes. Total body weight (TBW) and estimated glomerular filtration rate (eGFR) significantly affected metformin oral clearance. OCT2 c.390 G > T (p.Thr130 = , rs624249) was associated with metformin oral clearance and secretary clearance, whereas OCT3 c.-29G > A (rs555754) and c.360 C > T (p.Arg120 = , rs668871) were significantly associated with the absorption rate constant and oral clearance.

Conclusion

Metformin dosing in children can be optimized based on TBW, eGFR, and OCT2/3 genetic variants to improve its safety and efficacy.

Impact

Metformin pharmacokinetics is highly variable, and limited data are available on the pediatric population.

Total body weight and estimated glomerular filtration rate are associated with metformin oral clearance.

OCT2/3 genetic variants can influence the elimination and absorption of metformin.

Consideration of population factors associated with metformin pharmacokinetics in dose selection can improve its safety and efficacy.